EP0631509A1 - Verfahren und vorrichtung zur bluttrennung - Google Patents

Verfahren und vorrichtung zur bluttrennung

Info

Publication number
EP0631509A1
EP0631509A1 EP93906950A EP93906950A EP0631509A1 EP 0631509 A1 EP0631509 A1 EP 0631509A1 EP 93906950 A EP93906950 A EP 93906950A EP 93906950 A EP93906950 A EP 93906950A EP 0631509 A1 EP0631509 A1 EP 0631509A1
Authority
EP
European Patent Office
Prior art keywords
blood
container
fraction
pressure
outlet opening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93906950A
Other languages
English (en)
French (fr)
Inventor
Peter Unger
Eric Westberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Europe NV
Original Assignee
Terumo Europe NV
Omega Medicinteknik AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Europe NV, Omega Medicinteknik AB filed Critical Terumo Europe NV
Publication of EP0631509A1 publication Critical patent/EP0631509A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/029Separating blood components present in distinct layers in a container, not otherwise provided for

Definitions

  • the present invention relates to a method of separating blood into blood components and of transferring stratified components obtained by centrifugation to component containers and also to an arrangement of apparatus for trans ⁇ ferring the stratified components obtained by centrifugation to respective connected component containers.
  • Background Art Whole blood is collected in flexible blood containers to which one or more component containers are connected. In order to utilize the whole blood effec ⁇ tively, the blood collected is typically divided into three fractions, i.e. a plasma fraction, buffycoat fraction and cell concentrate fraction, of which two fractions are normally then transferred to their respective component containers. This division or stratification of the blood into said components is effected by centrifugation.
  • the plasma fraction which is the specifically lightest fraction
  • the erythrocyte fraction which is the specifically heaviest fraction
  • the buffycoat fraction is located therebetween.
  • the plasma fraction is the largest and therewith the most fluid of the components concerned.
  • the most common type of blood container has an outlet opening to which there is connected a pipe which has at least one branch line leading to individual blood-component containers. Normally, two component containers are connected to the blood container.
  • An arrangement for use in pressing stratified blood components from a blood container to respective component containers is known from EP-A- 0,348,682.
  • This known arrangement includes a vertical plate which is provided with means on which a blood container containing stratified blood component layers can be hung.
  • a second plate is mounted in the upper part of the first- mentioned plate, on a level with the upper limitation of the blood container. This second plate is pivotally mounted to the first plate by means of a vertical pivot axle spaced from said first plate.
  • the second plate When transferring the blood components to respective component containers, the second plate is brought into abutment with the blood container and exerts pressure thereonto until essentially all plasma fraction has been transferred to its intended container. This component container is then closed and the next fraction, which is the buffycoat fraction, is transferred to the second container. This second container is closed when all buffycoat has been transferred.
  • the erythrocyte fraction remains in the blood container.
  • One problem with this arrangement resides in the difficulty of transferring all of the buffycoat fraction to its intended container, since the buffycoat components have a highly pronounced tendency to adhere to the walls of the blood container and therewith contaminate the erythrocyte fraction that remains therein.
  • EP-A-0,446,713 discloses a blood bag system in which the lightest component, blood plasma, is pressed-out first and then the heaviest component, the red blood corpuscles, with the aid of a press means. This publication does not disclose the structural elements of the press means mentioned therein.
  • the blood bag system disclosed in this reference has two outlet openings in the upper limit of the container.
  • the first outlet opening is connected to the plasma component container by means of a first conduit
  • the second outlet opening is connected to the erythrocyte fraction container by means of a second conduit.
  • the second conduit has a length which enables it to extend to the bottom of the blood container.
  • Another blood bag system is known from US-A 4,608,178.
  • This system also includes a container with two outlet openings, one at the upper limit of the container and the other at its bottom limit.
  • the drawback with this known system is that it is much more expensive to produce in relation to systems which have openings solely at the upper container limit.
  • One object of the present invention is to provide a method of using a typical blood container having an outlet opening solely in the upper container limit while, at the same time, enabling the erythrocyte fraction to be removed from the container without being contaminated by the buffycoat fraction.
  • Another object of the invention is to enable the use of blood containers having two outlet openings in the upper container limit instead of one outlet opening at both the upper and the lower limit of said container.
  • a further object of the invention is to enable the use of blood containers which have no conduit that extends into the blood container and down to the container bottom.
  • Still a further object of the invention is to provide a simple arrangement with which blood components that have been stratified by centrifugation can be transferred from the blood container to their intended respective component containers connected to the blood container through the intermediary of one or two openings.
  • a method for separating blood into blood components comprising introducing blood into a blood container which has at least one blood component outlet opening in the upper limit of the container; centrifuging the blood container in a relatively high centrifugal field to form an upper plasma fraction, an intermediate buffycoat fraction and an erythrocyte fraction.
  • the method is characterized by applying pressure to the blood container so as to remove the plasma fraction through the outlet opening; forming in the blood container during said pressure applying stage or subsequent to said stage a connecting passage through which a second fraction is in communication with said outlet opening or with a second outlet opening; and then applying an elevated pressure to remove this second fraction through the connection passage thus formed.
  • the inventive method is carried out by means of an arrangement for removing blood components from a blood container having at least one outlet opening, in which the blood components exist in a stratified form subsequent to centrifuging blood.
  • the arrangement includes a housing which accommodates two first and second pressure plates which are movable relative to each other, a suspension means provided in the housing for positioning the blood container between the pressure plates, and means provided in the housing and functioning to move the pressure plates relative to one another and to create in the blood container an internal overpressure which can take both a lower and a higher value.
  • one of the pressure plates includes a mandrel which, when the blood container is compressed for the removal of the plasma fraction therefrom, forms a passage which connects the blood container outlet opening with the bottom fraction and which is not formed until the plasma fraction has been removed from the blood container.
  • Figure 1 is a schematic, sectional view of an arrangement for transferring stratified blood components to connected component containers;
  • Figure 2 is a schematic front view of a plate on which there is hung an empty, transparent blood container which is connected to two component containers, and also shows a pressure bladder mounted behind said plate;
  • Figure 3 illustrates schematically a second plate which coacts with the first plate to press blood fractions from the blood container into two component containers shown in Figure 2; and
  • Figure 4 is a schematic cross-sectional view of the plate in Figure 3, taken from the line A-A.
  • the apparatus illustrated in Figure 1 includes a housing 16 which is defined by a rear wall 13, a front wall 2, a floor 18 and side walls not shown.
  • Mounted on the front side of the bellows 15 is a first plate 3.
  • the front wall 2 forms a door which is hinged (not shown) to one of the side walls.
  • Gas is delivered to the bellows through an opening 14 in the rear wall 13, so as to move the front side of the bellows, and therewith also the plate 3, towards the front wall 2.
  • the gas source, control devices, hoses and connections to the opening 14 in the rear wall are not shown.
  • the first plate 3 is provided with suspension means 50 which function to support a blood container 1a on the front side of the plate 3.
  • the blood container 1a is connected by means of a hose or like conduit 19 to two component containers which are located outside the housing, which has no roof.
  • Mounted on the rear wall 13 and extending towards the front wall 2 are two guide rods 20. These guide rods 20 pass through openings in the plate 3 on each side of the blood container 1a and the bellows 15. The openings through which the rods 20 extend are configured so as to obviate the risk of sticking or jamming.
  • the front wall 2 coacts with the first plate 3 subsequent to said plate having been driven forwards by the bellows.
  • the front wall 2 will hereafter be referred to as the second plate 2.
  • the plate 2 is described in more detail with reference to Figure 3.
  • Figure 2 illustrates the first plate 3 with suspension means 50 comprising two arms from which there is hung a blood container having two openings 49 which are adapted to the suspension means 50.
  • the blood container 1a has an outlet opening 17 which connects the blood container with two component containers through the medium of a conduit 19.
  • the conduit 19 terminates in a three-way coupling 23 having connected thereto a conduit 21 which leads to a component container 1c, and a conduit 22 which leads to a component container 1b.
  • the blood container 1a also has an inlet opening and an inlet conduit 24 which is provided with a blood-tapping needle on the end thereof distal from the container.
  • the needle is fused-off and the conduit 24 therewith closed.
  • the first plate 3 only covers about half of the area of the blood contain ⁇ er, and then its upper half, but widens upwards and beyond the sides of the blood container 1a.
  • the plate 3 is provided on each side of the blood container 1 a with holes through which respective guide rods 20 ( Figure 1 ) are passed.
  • a groove 26 of inverted U cross-section is provided in that part of the plate 3 which lies against the blood container. This groove 26 coacts with a mandrel (bar) in the second plate 2.
  • the bellows 15 by means of which the first plate 3 is displaced is shown in broken lines.
  • An area 51 in the plate 3 located inwardly of the groove 26 may be sunken in relation to the remainder of the plate. This sunken area 51 is intended to take-up the buffycoat with the aid of the mandrel 5, when the plates 2 and 3 are pressed together.
  • the second plate 2 of the Figure 3 and Figure 4 illustration has a rectangular shape.
  • the contours of the blood container 1a when coacting with the first plate are indicated in broken lines, wherein reference numeral 6 indicates the joining line and the reference numeral 7 its outer contour.
  • the blood container 1a and the component containers typically consist of two mutually welded foil sheets.
  • a rectangular recess 9 having the shape of an inverted U is provided in the upper part of the plate 2.
  • a strip 4 is mounted in the recess 9.
  • Mounted between the strip 4 and the bottom 10 of the recess 9 are springs 8 which allow the strip 4 to move relative to the bottom of the recess and therewith relative to the upper surface of the plate 2.
  • the ends of the springs 8 are attached respectively to the strip 4 and the bottom 10 of the recess.
  • a mandrel in the form of a bar 5 is provided inwardly of the strip 4 and a mandrel in the form of a bar 5.
  • the bar 5 is attached to the plate 2 and projects out to a given distance from the plate surface, for instance a distance of 3-5 mm.
  • the bar 5 follows the inner defining line of the strip 4 slightly spaced therefrom or in contact therewith, although not to prevent the strip 4 from moving.
  • the top layer in the blood container 1a is comprised of blood plasma, which is the specifically lightest fraction.
  • the buffycoat fraction lies between these fractions.
  • the bellows 15 are located in a rearward position, which is the starting position of the bellows at the beginning of a blood component transfer operation.
  • the centrifuged blood container is hung on the suspension means 50 at the beginning of this transfer procedure.
  • the front wall or the second plate 2 is brought to the position shown in Figure 1. Gas, for instance air, is then delivered through the opening 14 in the rear wall 13, so as to inflate the bellows 15 and therewith drive the first plate 3 towards the second plate 2.
  • the lower part of the bellows 15 has roughly the same pres ⁇ sure area as the container 1a, while the upper part of the bellows has a much larger pressure area. Consequently, the upper part of the blood container is initially compressed more powerfully than its bottom part.
  • the connection to the component container 1c is initially open, while the connection to the second component container 1b is initially closed- As the blood container 1a comes into contact with the second plate, the liquid in the container is displaced and plasma begins to flow to the component container 1 c.
  • the blood container 1a will first come into contact with the strip 4 which, upon continued movement of the plate 3 towards the plate 2, will force the plasma fraction from the edge region of the container against which it abuts. Plasma will also flow through a passageway 11a which connects the interior of the blood container 1 a with the outlet opening 17.
  • the passageway 11 a is formed as a result of the pressure in the blood container 1a or through the medium of the passageway 11 in the strip 4.
  • the pressure exerted on the blood container 1 a is not sufficiently large to force the strip past the mandrel or bar 5 and into the grove 9. The pressure applied is thus counteracted by the force exerted by the springs 8.
  • the strip 4 has expelled plasma from said edge or border region, there is thus obtained a barrier with a passageway 11a through which plasma leaves the blood container 1 a.
  • the transference of plasma is terminated, for instance, when a predeter ⁇ mined quantity of plasma has been transferred or when a device, for instance a photocell, mounted adjacent the outlet opening 17 registers that all plasma has been transferred.
  • the conduit 21 leading to the container 1c and the conduit 22 are closed and opened respectively in a conventional manner and at a time point not described in detail here.
  • the purpose of this delay is to prevent hemolysis, which would otherwise occur if the erythrocytes were pressed through a passageway which was not fully open.
  • the pressure in the bellows 15 is increased when transfer of the plasma fraction is complete.
  • the pressure on the strip 4 will be so great as to overcome the force exerted by the springs and the mandrel 5 will press the container walls, which consist of plastic foil sheets, into the groove 26 in the plate 3.
  • the higher pressure in the bellows 15 provides a correspondingly high pressure in the blood container 1 a, this pressure causing the channel 33 to open fully.
  • the overpressure in the container 1a disappears when essentially the whole of the erythrocytes have been pressed out of the blood container 1 a.
  • the strip 4 will thereby be pressed by the springs 8 against the plate 3, so as to press out the cell content of the channel. Solely buffycoat will then remain in the blood container, enclosed in the space 51.
  • the ends of the strip 4 facing towards the blood container 1a are beveled to facilitate formation of said channel.
  • the channel 11 in said strip is intended to permit plasma to flow through a first outlet opening when using a blood container 1 a having two outlet openings, one for plasma fraction and one for erythrocyte fraction, in the upper limit of the container.
  • the mandrel 5 and the strip 4 may be arranged on the first plate 3 instead of on the second plate 2. In this case, the groove 26 in the opposing plate and coacting with the mandrel 5 will be provided in the second plate.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
EP93906950A 1992-03-19 1993-03-18 Verfahren und vorrichtung zur bluttrennung Withdrawn EP0631509A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9200857 1992-03-19
SE9200857A SE9200857D0 (sv) 1992-03-19 1992-03-19 Saett och anordning foer uttag av blodkomponenter
PCT/SE1993/000233 WO1993018804A1 (en) 1992-03-19 1993-03-18 Blood separation method and apparatus

Publications (1)

Publication Number Publication Date
EP0631509A1 true EP0631509A1 (de) 1995-01-04

Family

ID=20385678

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93906950A Withdrawn EP0631509A1 (de) 1992-03-19 1993-03-18 Verfahren und vorrichtung zur bluttrennung

Country Status (3)

Country Link
EP (1) EP0631509A1 (de)
SE (1) SE9200857D0 (de)
WO (1) WO1993018804A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6994790B2 (en) 2002-02-01 2006-02-07 Gambro, Inc. Whole blood collection and processing method
CA2539153A1 (en) * 2003-09-22 2005-04-07 James F. Mank Press for removing supernatant from a flexible vessel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815643A1 (de) * 1988-05-07 1989-11-30 Biotest Pharma Gmbh Vorrichtung zur trennung von komponenten einer fluessigkeit, insbesondere von gesamtblut
US4976851A (en) * 1988-06-06 1990-12-11 Terumo Kabushiki Kaisha Liquid separator
US5102407A (en) * 1990-03-13 1992-04-07 Miles Inc. Blood separation system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9318804A1 *

Also Published As

Publication number Publication date
SE9200857D0 (sv) 1992-03-19
WO1993018804A1 (en) 1993-09-30

Similar Documents

Publication Publication Date Title
US5632906A (en) Apparatus and method for transferring separated component in liquid from a flexible bag in a centrifugal container
US5140801A (en) Apparatus for filling folded sheet bags
AU619012B2 (en) Liquid separator
US4350585A (en) Device for blood separation
EP0484751B1 (de) Trennungssystem im Boden von Blutbeuteln
EP0235244B1 (de) Verfahren und vorrichtung zur trennung von serum und plasma aus blut
EP0535143B1 (de) Verfahren und vorrichtung zur bluttrennung
US5120305A (en) Method and apparatus for delivering or withdrawing fluids
US5061451A (en) Device for separating the components of a liquid, especially whole blood
US5874208A (en) Method and apparatus for harvesting blood components
JPH0347266A (ja) 液体分離装置
WO1993018804A1 (en) Blood separation method and apparatus
EP0608882B1 (de) Vorrichtung zur Trennung von Flüssigkeiten
EP1663800B1 (de) Presse zur Entfernung von Überstand aus einem flexiblen Behälter
JP3167478B2 (ja) 液体分離装置
JP2003135591A (ja) 血液成分分離装置
EP1556100A1 (de) Trennvorrichtung für die bestandteile einer flüssigkeit
JP3184052B2 (ja) 血液成分分離装置
JP2528058B2 (ja) 血液成分分離装置
JP3868261B2 (ja) 血液成分分離装置
CN113069614B (zh) 全自动单袋血液成分分离装置
JPH04269970A (ja) 血液成分分離装置
CN115892631A (zh) 挤压热合装置
JP2941177B2 (ja) 血液成分分離機
JPH08280791A (ja) 血液成分分離装置

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19941016

17Q First examination report despatched

Effective date: 19960305

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TERUMO EUROPE N.V.

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970826